Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines - Wikidata - wikimedia - TriplyDB

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

http://www.wikidata.org/entity/Q28145996

about

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones The toxicology of bath salts: a review of synthetic cathinones Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone Pharmacological characterization of designer cathinones in vitro Methylone and mCPP, two new drugs of abuse?Substituted methcathinones differ in transporter and receptor interactions The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs Generation of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinones.Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones.Neurochemical profiles of some novel psychoactive substances Neurotoxicity Induced by Mephedrone: An up-to-date Review.Bupropion: pharmacology and therapeutic applications.Methylone and monoamine transporters: correlation with toxicity Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues.Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues.Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.Bath salts: the ivory wave of trouble.Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice.Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.Psychoactive "bath salts": not so soothing.Lethal serotonin syndrome after methylone and butylone ingestion Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs Synthetic cathinone abuse The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats.Cathinone derivatives: a review of their chemistry, pharmacology and toxicology.GHB and synthetic cathinones: clinical effects and potential consequences.

P2860

Q24615008-C0169DF9-AF59-415D-93A4-A363718134BF Q24621938-212323E5-FD93-48CF-817C-65A181C4F31A Q24629270-28B2F166-EB04-4392-9A13-B5A10F613C11 Q24631675-A0DEC58E-45C5-4508-8E53-C438C3B68CC3 Q28249380-9387B0D3-6D3A-4446-A176-74DADD9E27F0 Q28253719-4BEE4302-97FA-43C4-9120-9F409D54E53D Q28264655-30644A57-0877-4895-928C-664EF80E376C Q28273207-4B1630E1-4093-43B8-8DD3-6499C8E8E231 Q28284527-99E35C30-C573-40AF-AC86-6470DA6E6A6B Q28288908-A90D1982-C72E-4D52-8FFF-49EC9C9F58C6 Q28950585-B3D3D60A-312C-496D-9DC6-4641EAC0C149 Q33566201-1B6635FC-3B9F-405C-805F-79DDBE5EC649 Q34122399-733303BE-3056-47B3-99BD-89370B77AE22 Q34122902-BA128662-C5FB-4AFC-9C71-160F5593E897 Q34149434-5B4784E3-2AF6-41EF-BA5F-660E59341742 Q34206558-DC35117D-F92A-4D64-9368-3A3FDE1FA251 Q34280393-D12B7EBA-17A2-4ACE-BC28-C0EF25A25622 Q34319162-38AD540F-9D25-4D7E-9A63-2418BC131D74 Q34546425-AC467EAD-1106-4855-962F-0068F98ECB6A Q34569990-3CBCFF7A-2CE1-49C1-B32A-54A8991A8884 Q35107886-C6B6901B-ECDD-43EA-8897-5544034BAF46 Q35484280-F42876AC-9A64-4392-900E-9229791E2B21 Q35538485-53D82F04-5942-40F4-A5BE-3B69FABF0EC5 Q35754464-529C05C9-B562-4291-8D95-8C07D9ABE135 Q35817281-C86A143F-535A-43C7-BCDD-33892DFE4BE8 Q36036018-42ACB74D-032C-4490-BB76-7B823193EB15 Q36092017-CE36C7D0-613D-4ED1-8C82-DCA629D51FB5 Q36329494-15BD5489-C74F-42C7-AA3E-DEAA11902237 Q36432300-2D1A1DB2-D8DA-4DF9-9696-971488815DE5 Q36509367-BBFC25E4-0E82-459C-99C1-62A8FB603765 Q36548942-2A89D34E-DAE2-4B30-B4FB-D32565B7E928 Q36610017-EE79CA7C-493E-4CD2-9738-11DFA5A93B69 Q36703786-E908F253-6B61-4AB4-9C80-52D76985C84A Q36851442-5CCC92B4-A2AE-4AAF-AA56-DAB1356BB631 Q36996570-454A5246-774A-40A5-9EF9-4D06167BC1EF Q37310323-499FDA2C-C224-426D-8415-D34C5AF991C4 Q37381303-D1F9E9D3-6E6C-4EC8-9B17-831F1AB605ED Q37424592-00DD10E1-C651-42A6-9618-27EA0076973A Q37900939-33473DF0-9618-4F40-A04E-376D348207B6 Q37940942-D5413AD0-383C-45F4-8B21-81E5E846FC13

P2860

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

http://www.wikidata.org/entity/Q28145996

description

1999 nî lūn-bûn

@nan

1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@ast

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@en

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@nl

type

label

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@ast

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@en

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@nl

prefLabel

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@ast

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@en

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@nl

P1433

Q28145996-68CDD3E5-3181-402F-8F8E-89CC56AA4F4C

P1476

Q28145996-A3B06BBF-04AD-418A-9776-6676F5C3A1A9

P2093

Q28145996-07CB2AA0-E80D-41FE-BA4E-D833C4165E07

Q28145996-372B373B-9954-429E-99E1-ED12581D3FE9

Q28145996-76168F34-FB5A-41AB-8545-9AAFC1466AA7

Q28145996-A5008C79-7A4F-424E-A9D6-E13FF9817997

Q28145996-BFA04522-1EDB-4DF8-A981-78EB3020A186

P304

Q28145996-99EE6A37-BDD1-49A3-BA93-6685CF4DE9AB

P31

Q28145996-82E8E62A-2996-432E-93CC-8E0F5A62AB7C

P356

Q28145996-D9546CC9-62CB-48B8-B010-D3BB253D9676

P407

Q28145996-957986B8-4704-43D1-8E91-34AF9B6B64A2

P433

Q28145996-772E9C2F-A417-44EC-B9D7-5E4F6AF46688

P478

Q28145996-0887E02F-E08D-48F6-92F0-8F090FF6C5AD

P577

Q28145996-2E7C819A-D563-4D17-B75F-2F0B889D3DDF

P5875

Q28145996-C370E486-5CA2-406C-A83F-49A787DBD147

P698

Q28145996-3F2F4FD8-AF58-44D0-A6CA-29EBA3A2E204

P356

S0014-2999(99)00538-5

P1433

European Journal of Pharmacology

P1476

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

@en

P2093

A E Ruoho

http://www.w3.org/2001/XMLSchema#string

A T Shulgin

http://www.w3.org/2001/XMLSchema#string

M K Sievert

http://www.w3.org/2001/XMLSchema#string

N V Cozzi

http://www.w3.org/2001/XMLSchema#string

P Jacob

http://www.w3.org/2001/XMLSchema#string

P304

63-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0014-2999(99)00538-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

381

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

222441006

http://www.w3.org/2001/XMLSchema#string

P698

10528135

http://www.w3.org/2001/XMLSchema#string